Immune-Related Biomarkers: 2nd Edition
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Biomarkers".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 16008
Special Issue Editors
Interests: inflammation; innate immunity; cellular immunology; animal physiology; immunology; physiology; molecular biology; biotechnology; cell biology; cell culture
Special Issues, Collections and Topics in MDPI journals
Interests: neuroimmunology; multiple sclerosis (clinical/experimental); animal models; glial cells; immune tolerance
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Following a very successful first run, we are pleased to announce the launch of a second edition of the Special Issue “Immune-Related Biomarkers”.
In recent years, there has been a paradigm shift in the view of the immune system's involvement in many diseases.
The immune system is now known to be involved in many more diseases and to play a more important role in diseases occurring in old age than initially assumed. Its significance is becoming more apparent in diseases that were thought to be consequences of purely degenerative processes; many also have an active inflammatory component or are triggered by immune system reactions. The immune system is controlled by an intricate network of interacting signaling pathways and processes, many of which remain incompletely understood. Biomarkers for the stratification of different diseases or as generalized markers of a dysfunctional immune system should be used as a non-invasive molecular technology to assist in the prediction, diagnosis, prevention, and treatment of a variety of diseases.
Therefore, we invite the submission of review articles focusing on biomarkers suitable for this purpose. Critical articles regarding the flood of biomarkers that have already been proposed but failed to deliver on their promises in precision medicine are also welcome. In addition, we welcome any original work that makes a significant contribution to technical advances—whether in sample preparation, analytical methods, or bioinformatics data analysis—or that contributes to a better understanding of disease in terms of prediction, diagnosis, prevention, and treatment.
We would like to point out that, at the moment, the scope of our journal is mainly focused on basic science, in vitro, in vivo, and pre-clinical research, while purely clinical studies are usually not processed.
Prof. Dr. Cornelia Deeg
Dr. Jelena Skuljec
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immune biomarker
- proteomics
- O-link
- molecular medicine
- prediction of disease
- diagnosis/stratification of diseases
- targeted immune therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
Related Special Issue
- Immune-Related Biomarkers in Biomolecules (12 articles)